LensAR wins FDA clearance for its next-gen laser system

The FDA OKs LensAR's laser system for executing corneal incisions, giving the system full indications for all the critical components of laser cataract surgery.

Orlando, Fla.-based LensAR [1] won additional FDA clearance for its next-generation LensAR laser system, gaining indication for performing corneal incisions during cataract surgery.

With the latest regulatory win the LensAR system is cleared for all critical aspects of laser cataract surgery, including lens fragmentation, anterior capsulotomy and corneal incisions, according to the press release.